MedTrace Logo

A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss

NCT03793153 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2019-04-09

No results posted yet for this study

Summary

Study aim to evaluate the efficacy and safety of a novel technique of UTERINE COOLING during repeated cesarean section (CS) in reducing blood loss, and record any adverse effects following it.

Conditions

  • Cesarean Section Complications
  • Intrapartum Hemorrhage
  • Postpartum Hemorrhage
  • Atony, Uterine

Interventions

PROCEDURE

Uterine Cooling Technique

Standard LSCS will be done except immediatelyfollowing delivery of the fetus the uterus will beexternalized in the usual fashion and the body of theuterus cephalad to the hysterotomy incision will bewrapped in sterile surgical towels saturated in sterile,iced normal saline. These towels will come from asterile cooling pot set to 30 degrees Fahrenheit. Theskin of the abdomen will be draped to prevent contactwith the cold towels. Iced saline-soaked towels will bekept in place for a minimum of 5 minutes and replacedat the discretion of the attending obstetrician until thehysterotomy is closed and the uterus is replaced intothe patient's abdomen.

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Amro M. Hetta, M. Sc. · OB/GYN Departments, Al-Hussein University Hospital, Al-Azhar University

  • Abdallah K. Ahmed, MD · OB/GYN Departments, Al-Hussein University Hospital, Al-Azhar University

  • Mofeed F. Mohamed, MD · OB/GYN Departments, Al-Hussein University Hospital, Al-Azhar University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-19
Primary Completion
2019-03-20
Completion
2019-03-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793153 on ClinicalTrials.gov